<DOC>
	<DOCNO>NCT01268332</DOCNO>
	<brief_summary>The purpose study evaluate safety adherence non-medicated IVR HIV uninfected woman 12 week use .</brief_summary>
	<brief_title>Safety Adherence Non-medicated Intravaginal Ring ( IVR )</brief_title>
	<detailed_description>Women comprise grow proportion new HIV infection worldwide . Intravaginal ring ( IVRs ) use deliver microbicides potential significantly reduce heterosexual transmission HIV find safe , acceptable , effective HIV infection . This study investigate safety acceptability non-medicated silicone elastomer IVR sexually active HIV uninfected woman . The expected duration study participant 16 week . Study participant randomly assign one two arm . Participants Group A insert IVR vagina study entry . The IVR remain place 12 week remove physician . Follow continue additional 4 week IVR removal . Participants Group B receive IVR , follow study schedule Group A .</detailed_description>
	<criteria>HIV uninfected General good health Sexually active Agree use effective method contraception Normal Pap smear result within 12 month prior study entry Agree participate drug device research study duration study participation Agree use intravaginal product duration study participation History adverse reaction silicone , latex , titanium dioxide Current male sex partner know history adverse reaction silicone , latex , titanium dioxide Last pregnancy outcome within 30 day less prior enrollment History hysterectomy Any abnormal pelvic exam find Pregnant Condition , opinion investigator , would interfere study Severe pelvic relaxation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Placebo IVR delivery method</keyword>
</DOC>